4/24
11:12 am
mor
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting [Yahoo! Finance]
Low
Report
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting [Yahoo! Finance]
4/24
10:40 am
mor
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
Low
Report
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
4/24
10:37 am
mor
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/19
11:35 am
mor
Novartis Looks To Get Back On Track With Q1 Earnings [Seeking Alpha]
Low
Report
Novartis Looks To Get Back On Track With Q1 Earnings [Seeking Alpha]
4/11
02:44 pm
mor
German biopharma MorphoSys recommends Novartis offer be accepted [Yahoo! Finance]
Low
Report
German biopharma MorphoSys recommends Novartis offer be accepted [Yahoo! Finance]
4/11
11:41 am
mor
Novartis (NVS) to Undertake Job Cuts in Development Department [Yahoo! Finance]
Low
Report
Novartis (NVS) to Undertake Job Cuts in Development Department [Yahoo! Finance]
4/11
09:00 am
mor
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
Low
Report
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
4/11
08:46 am
mor
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis [Yahoo! Finance]
Neutral
Report
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis [Yahoo! Finance]
4/11
08:39 am
mor
MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
Low
Report
MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
4/11
06:44 am
mor
UPDATE 2-Novartis begins tender offer for cancer-focused MorphoSys [Yahoo! Finance]
Low
Report
UPDATE 2-Novartis begins tender offer for cancer-focused MorphoSys [Yahoo! Finance]
4/11
05:50 am
mor
Novartis commences tender offer for MorphoSys [Seeking Alpha]
Low
Report
Novartis commences tender offer for MorphoSys [Seeking Alpha]
4/11
05:00 am
mor
Novartis begins tender offer for MorphoSys [Reuters]
Low
Report
Novartis begins tender offer for MorphoSys [Reuters]
4/11
04:26 am
mor
Novartis tender offer for MorphoSys AG commences [Yahoo! Finance]
Low
Report
Novartis tender offer for MorphoSys AG commences [Yahoo! Finance]
4/4
01:11 am
mor
Novartis: Higher Guidance, Now A Buy [Seeking Alpha]
Low
Report
Novartis: Higher Guidance, Now A Buy [Seeking Alpha]
3/29
08:16 am
mor
HI-Bio to Present at the 61st European Renal Association (ERA) Congress [Yahoo! Finance]
Low
Report
HI-Bio to Present at the 61st European Renal Association (ERA) Congress [Yahoo! Finance]
3/22
10:33 am
mor
MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis [Seeking Alpha]
Low
Report
MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis [Seeking Alpha]
3/22
05:09 am
mor
European Stocks on Track for Longest Winning Run Since 2012 [BNN Bloomberg (Canada)]
Low
Report
European Stocks on Track for Longest Winning Run Since 2012 [BNN Bloomberg (Canada)]
3/22
03:04 am
mor
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act [Yahoo! Finance]
Low
Report
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act [Yahoo! Finance]
3/22
02:50 am
mor
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Low
Report
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
3/21
08:14 am
mor
HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients [Yahoo! Finance]
Low
Report
HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients [Yahoo! Finance]
3/15
10:58 am
mor
MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/14
04:01 pm
mor
MorphoSys AG (NASDAQ: MOR) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company.
Low
Report
MorphoSys AG (NASDAQ: MOR) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company.
3/13
04:13 pm
mor
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/13
04:02 pm
mor
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Low
Report
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
3/12
04:56 pm
mor
German competition regulator clears path for Novartis takeover of MorphoSys [Reuters]
Low
Report
German competition regulator clears path for Novartis takeover of MorphoSys [Reuters]